DAVID ANUOLUWAPO OYENIRAN

Mr. DAVID ANUOLUWAPO OYENIRAN

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2025 in Neuroglia
Verified
Journal Article
Open access
PDF file
OIOlayemi Kafilat Ijomone
Olayemi Kafilat Ijomone
IUIleje Inelo Ukwubile
Ileje Inelo Ukwubile
OAOluoma Vivian Aneke
Oluoma Vivian Aneke
TOTobiloba S Olajide
Tobiloba S Olajide
HIHappiness Ochi Inyang
Happiness Ochi Inyang
OIOmamuyovwi Ijomone
Omamuyovwi Ijomone
Overexposure of humans to heavy metals and essential metals poses a significant risk for the development of neurological and neurodevelopmental disorders. The mechanisms through which these metals exert their effects include the generation of reactive oxygen species, mitochondrial dysfunction, activation of inflammatory pathways, and disruption of cellular signaling. The function of glial cells in brain development and in the maintenance of homeostasis cannot be overlooked. The glial cells are particularly susceptible to metal-induced neurotoxicity. Accumulation of metals in the brain promotes microglial activation, triggering inflammatory responses that can coincide with other mechanisms of neurotoxicity, inducing alteration in synaptic transmission, cognitive deficit, and neuronal damage. In this review, we highlighted the role of glial dysfunction in some selected neurodegenerative diseases and neurodevelopmental disorders. We further dive into how exposure to metals such as nickel, manganese, methyl mercury, cadmium, iron, arsenic, and lead affect the functions of the microglia, astrocytes, and oligodendrocytes and the mechanisms through which they exert the effects on the brain in relation to some selected neurodegenerative diseases and neurodevelopmental disorders. Potential therapeutic interventions such as the use of new and improved chelating agents and antioxidant therapies might be a significant approach to alleviating these metal-induced glial perturbations.

4 July 2026 in Metabolic Brain Disease
Verified
Journal Article
Closed access
VAVictor Ebube Anadu
Victor Ebube Anadu
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb
TGTolulope Judah Gbayisomore
Tolulope Judah Gbayisomore
DODAVID ANUOLUWAPO OYENIRAN
DAVID ANUOLUWAPO OYENIRAN
FAFrancis T. Adeniran
Francis T. Adeniran
OIOmamuyovwi Ijomone
Omamuyovwi Ijomone

28 February 2025
Verified
Book Chapter
Closed access
DODAVID ANUOLUWAPO OYENIRAN
DAVID ANUOLUWAPO OYENIRAN
TOTobiloba Samuel Olajide
Tobiloba Samuel Olajide
AAAbayomi Oyeyemi Ajagbe
Abayomi Oyeyemi Ajagbe
AMAbdulateef Ayoola Mobolaji
Abdulateef Ayoola Mobolaji

30 April 2025
Verified
Book Chapter
Open access
PDF file
GOGideon Olamilekan Oluwatunase
Gideon Olamilekan Oluwatunase
POPatrick Godwin Okwute
Patrick Godwin Okwute
OAOlayinka Olawale Asafa
Olayinka Olawale Asafa
DODAVID ANUOLUWAPO OYENIRAN
DAVID ANUOLUWAPO OYENIRAN
BOBright OGHENETEGA
Bright OGHENETEGA
The model organism Caenorhabditis elegans (C. elegans) is a microscopic roundworm discovered in 1900, which is widely becoming an acceptable animal model of human diseases in the scientific community, particularly in neurobiology and genetic research. C. elegans is considered of great interest to neuroscientists for studying basic biological processes and understanding neurodegenerative and neurodevelopmental disorders because of its small size, fully sequenced genome, simple and transparent body structure, and short life span. This chapter highlights the use of C. elegans in modeling diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS), alongside its contributions to neurodevelopmental and behavioral studies. Furthermore, advanced tools like CRISPR/Cas9 and RNA interference have augmented its utility, making it invaluable for therapeutic discovery and understanding gene-environment interactions. Challenges and future prospects are also presented hereon.